Last reviewed · How we verify

NCT05933798

China Pilot of ICOPE (Integrated Care for Older People) in Chaoyang

Completed NA Last updated 6 July 2023
What this trial tests

NA trial testing ICOPE in Aging in 2,148 participants. Completed in 31 August 2021.

Timeline
1 September 2020
Primary endpoint
31 July 2021
31 August 2021

Quick facts

Lead sponsorPinetree Health Technologies (Beijing) Co., Ltd.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment2,148
Start date1 September 2020
Primary completion31 July 2021
Estimated completion31 August 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Pinetree Health Technologies (Beijing) Co., Ltd.

Who can join

60 and older, any sex, with Aging or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this pilot study is to examine predefined parameters (sample size, capacity building, acceptance by community-dwelling older people (participants) and care providers) to evaluate the feasibility of implementing World Health Organization's ICOPE (integrated care for older people) approach in China. The main questions it aims to answer are: 1. Whether it is feasible to implement the ICOPE approach in China; 2. Whether the integrated care approach would make any difference in health outcomes and resource utilization. Participating older adults receiving integrated care (Intervention Group) are compared to those receiving usual care (Control Group) in order to answer the two questions above.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05933798.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing